Clinical trial
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast…
NCT00032136 · Cancer Research Campaign Clinical Trials Centre, Other · Completed
Key facts
| NCT number | NCT00032136 |
|---|---|
| Title | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer |
| Official title | An Open Label, Randomized Multicenter Comparative Trial Of 5 Years Adjuvant Exemestane Treatment Versus 5 Years Adjuvant Tamoxifen Treatment In Postmenopausal Women With Early Breast Cancer |
| Lead sponsor | Cancer Research Campaign Clinical Trials Centre, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | exemestane, tamoxifen citrate, adjuvant therapy |
| Enrollment | 4,400 |
| Start date | Dec 1, 2001 |
| Completion | Apr 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: